London-based health tech startup Stitch has raised £2.5 million in funding to get the product in the hands of more patients. The seed round was led by Connect Ventures, with participation from Form Ventures, Boost Capital, and angel investors.
Founded in 2021 by Jonathan Moshinsky, Mike Sterling and James Allen, Stitch aims to make clinical trials better by measuring each patient’s experience. The platform helps patients manage their trial journey and share their feedback, enabling research sponsors to improve patient experience, and trial design, and retain more patients on trial.
Jonathan Moshinsky, co-founder and CEO of Stitch said: “It’s fantastic to be working with such an exceptional partner, Connect Ventures, who share our vision of a world where each patient on every clinical trial is supported and heard throughout their journey.”
Sitar Teli, managing partner at Connect Ventures, added: “Patients are the critical participants in clinical trials, but their experience is one of poor communication, frustration and neglect. Stitch is building a patient-centric product for clinical trials. It enables sponsors to communicate trial protocol clearly and conveniently and patients to give feedback on their experience in real-time, improving patient retention and success rates.”